Stay updated with breaking news from Total Identity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a report published on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. Conformis Trading Up 87.1 […]
StockNews.com started coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a report issued on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered shares of Conformis from an outperform rating to a market perform rating in a research report on Tuesday, May 9th. Conformis Stock […]
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut shares of Conformis from an outperform rating to a market perform rating in a report on Tuesday, May 9th. […]
StockNews.com started coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a research report released on Monday. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered shares of Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. Conformis Stock […]
Research analysts at StockNews.com started coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a report issued on Monday. The brokerage set a “hold” rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut shares of Conformis from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 9th. […]